← Evidence map

ArticleCancer cell international2022

Tiliroside suppresses triple-negative breast cancer as a multifunctional CAXII inhibitor.

Rui Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36424626